Anti-PD-1 Therapy in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma
Clinical trial NCT07751289 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07751289
- Sponsor
- Yanjie Zhang, MD
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2029-12-31
- Enrollment
- 217
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.